These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 23214096)
21. [Combination therapy of disease-modifying antirheumatic drugs(DMARDs) in rheumatoid arthritis]. Kobayashi S; Kanai Y Nihon Rinsho; 2002 Dec; 60(12):2351-6. PubMed ID: 12510361 [TBL] [Abstract][Full Text] [Related]
22. Current concepts in the management of rheumatoid arthritis. Murphy NG Del Med J; 1992 Apr; 64(4):257-64. PubMed ID: 1352263 [No Abstract] [Full Text] [Related]
24. Superficial Tissue Necrosis Related to Methotrexate Injection in a Patient With Rheumatoid Arthritis. Estrada Alarcon PV; García-Díaz S; Oña M; Corominas H J Clin Rheumatol; 2015 Oct; 21(7):370. PubMed ID: 26398466 [No Abstract] [Full Text] [Related]
25. Safe prescribing of methotrexate for rheumatoid arthritis. Kirkham BW Med J Aust; 1995 Sep; 163(5):278. PubMed ID: 7565224 [No Abstract] [Full Text] [Related]
26. The selective estrogen receptor alpha agonist Org 37663 induces estrogenic effects but lacks antirheumatic activity: a phase IIa trial investigating efficacy and safety of Org 37663 in postmenopausal female rheumatoid arthritis patients receiving stable background methotrexate or sulfasalazine. van Vollenhoven RF; Houbiers JG; Buttgereit F; In 't Hout J; Boers M; Leij S; Kvien TK; Dijkmans BA; Szczepański L; Szombati I; Sierakowski S; Miltenburg AM Arthritis Rheum; 2010 Feb; 62(2):351-8. PubMed ID: 20112368 [TBL] [Abstract][Full Text] [Related]
27. Prednisone Use and Risk of Mortality in Patients With Rheumatoid Arthritis: Moderation by Use of Disease-Modifying Antirheumatic Drugs. Chester Wasko M; Dasgupta A; Ilse Sears G; Fries JF; Ward MM Arthritis Care Res (Hoboken); 2016 May; 68(5):706-10. PubMed ID: 26415107 [TBL] [Abstract][Full Text] [Related]
28. [Effective combination therapy of TNF antagonists with DMARDs]. Ohtsubo H; Matsuda T Nihon Rinsho; 2007 Jul; 65(7):1287-91. PubMed ID: 17642245 [TBL] [Abstract][Full Text] [Related]
29. [Diagnosis and treatment of rheumatoid arthritis]. Misiūniene N; Baranauskaite A Medicina (Kaunas); 2002; 38(1):110-6. PubMed ID: 12474726 [TBL] [Abstract][Full Text] [Related]
30. What dose of folic acid to use with methotrexate in rheumatoid arthritis? Bramley D Drug Ther Bull; 2021 Jul; 59(7):103-106. PubMed ID: 34162667 [No Abstract] [Full Text] [Related]
36. Parenteral methotrexate for the treatment of rheumatoid arthritis. Yazici Y; Bata Y Bull Hosp Jt Dis (2013); 2013; 71 Suppl 1():46-8. PubMed ID: 24219041 [TBL] [Abstract][Full Text] [Related]
37. Combination therapy for rheumatoid arthritis: new paradigms of treatment. Wilke WS Cleve Clin J Med; 1993; 60(2):101-2. PubMed ID: 8095190 [No Abstract] [Full Text] [Related]
38. Methotrexate-related minor adverse effects in rheumatoid arthritis: more than a nuisance. Dhir V; Aggarwal A J Clin Rheumatol; 2012 Jan; 18(1):44-6. PubMed ID: 22157277 [No Abstract] [Full Text] [Related]
39. Renal safety of initial combination versus single DMARD therapy in patients with early rheumatoid arthritis: an 11-year experience from the FIN-RACo Trial. Karstila KL; Rantalaiho VM; Mustonen JT; Möttönen TT; Hannonen PJ; Leirisalo-Repo M; Kaipiainen-Seppänen OA; Karjalainen AH; Korpela MM; Clin Exp Rheumatol; 2010; 28(1):73-8. PubMed ID: 20346242 [TBL] [Abstract][Full Text] [Related]
40. Methotrexate versus leflunomide in rheumatoid arthritis: what is new in 2011? Singer O; Gibofsky A Curr Opin Rheumatol; 2011 May; 23(3):288-92. PubMed ID: 21378570 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]